Site icon pharmaceutical daily

Inhalers Medical Devices Pipeline Assessment

BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Inhalers – Medical Devices Pipeline Assessment, 2019” report has been added to ResearchAndMarkets.com’s offering.

The Medical Devices sector report provides an overview of Inhalers currently in pipeline stage. The report provides comprehensive information on pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Inhalers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Scope

Reasons to Buy

The report enables you to –

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Inhalers Overview

3 Products under Development

3.1 Inhalers – Pipeline Products by Stage of Development

3.2 Inhalers – Pipeline Products by Segment

3.3 Inhalers – Pipeline Products by Territory

3.4 Inhalers – Pipeline Products by Regulatory Path

3.5 Inhalers – Pipeline Products by Estimated Approval Date

3.6 Inhalers – Ongoing Clinical Trials

4 Inhalers – Pipeline Products under Development by Companies

4.1 Inhalers Companies – Pipeline Products by Stage of Development

4.2 Inhalers – Pipeline Products by Stage of Development

5 Inhalers Companies and Product Overview

6 Inhalers- Recent Developments

6.1 May 04, 2019: Vectura wins US GSK patent litigation and awarded $89.7Million in damages by trial jury

6.2 May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury

6.3 May 03, 2019: Novo Nordisk’s operating profit increased by 14% in Danish kroner and by 8% at constant exchange rates (CER) in the first three months of 2019

6.4 May 02, 2019: Teva reports first quarter 2019 financial results

6.5 May 01, 2019: United Therapeutics reports first quarter 2019 financial results

6.6 May 01, 2019: GSK delivers sales of 7.7 billion +6% AER, +5% CER

6.7 Apr 30, 2019: Novo Nordisk to achieve target of 100% renewable power in production and launches new ambition aiming for zero environmental impact

6.8 Apr 30, 2019: Adherium: Appendix 4C- Quarterly cash flow report to 31 March 2019

6.9 Apr 25, 2019: 3M reports first-quarter 2019 results; company initiates restructuring

6.10 Apr 25, 2019: Orion Group Interim report January-March 2019

7 Appendix

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/ihrhgz

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics: Medical Devices, Inhalers and Nebulisers, Respiratory Devices

Exit mobile version